Antimicrobial resistance diagnostics
4 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE
Lyon-based translational research institute specializing in preclinical validation of vaccines, antibiotics, and immunotherapies against infectious diseases.
“VALUE-Dx addresses AMR through diagnostic optimization and health economics evaluation.”
FR8 projects - CLINICAGENO LIMITED
UK diagnostics SME combining point-of-care lab-on-a-chip platforms with health data federation and clinical genomics expertise.
“DIAGORAS specifically targeted identification of antibiotic resistance alongside pathogen detection.”
SMEUK3 projects - MICROPATHOLOGY LIMITED
UK diagnostics SME specializing in molecular detection and RNA-based personalised diagnosis of infectious and febrile diseases.
“PERFORM addressed antibiotic resistance as a key challenge, with better diagnostics reducing unnecessary antibiotic prescriptions.”
SMEUK3 projects - NANOSYNEX LTD
Israeli medtech SME building ultra-fast antimicrobial susceptibility tests so doctors can pick the right antibiotic in hours, not days.
“Both projects explicitly target diagnosing antimicrobial resistance to guide treatment decisions.”
PrimarySMEIL2 projects